PER-060-05已完成未知
Bone Substudy: Phase III Study to Evaluate Letrozole as Adjuvant Endocrine Therapy in Post-Menopausal Women with Positive Tumors for Estrogenic and / or Progestogenic Receptors (RE and / or RP), according to Protocol BIG 1-98
OVARTIS BIOSCIENSES PERU S.A.,0 个研究点目标入组 4 人开始时间: 2005年11月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •1. Patients in the BIG 1-98 Trial without known, symptomatic bone disease.
- •2. Patients who have not yet completed 5 years of trial treatment and who have not had recurrence of breast cancer or a second primary cancer.
- •3. Written informed consent must be obtained and must be signed and dated by the patient and the investigator.
排除标准
- •1. Uncontrolled thyroid and parathyroid disease, Cushing´s disease or other pituitary diseases.
- •2. Any known bone disease.
- •3. Malabsorption syndrome or clinically relevant vitamin D deficiency.
- •4. Use of raloxifene at any time.
- •5. Patients in whom the determination of bone density is impossible.
- •6. Record prior to the Bone Mineral Density sub-study of BIG 1-98.
研究者
相似试验
已完成
3 期
Adjuvant Therapy for Postmenopausal Patients with Operable Breast Cancer who have Estrogen Receptor or Progesterone Receptor Positive Tumors.Tamoxifen vs. Letrozole vs. Tamoxifen followed by Letrozole vs. Letrozole followed by TamoxifeBreast CancerACTRN12607000012471ovartis Pharma AG, Basel6,193
已完成
不适用
A Phase III Study to Evaluate Letrozole as Adjuvant Endocrina Therapy for Postmenopausal Women with Receptor (ER and/or PgR) Positive Tumors-C509 Breast, unspecifiedBreast, unspecifiedC509PER-051-00OVARTIS BIOSCIENSES PERU S.A.,
尚未招募
Unknown
Investigating the effect of letrozole in the treatment of ectopic pregnancyEctopic pregnancyIRCT20220902055855N1Tehran University of Medical Sciences75
招募中
不适用
Phase II study of efficacy of letrozole in postmenopausal patients with endocrine-responsive, HER2-negative metastatic breast cancer resistant to exemestane or anastrozole.Metastatic breast cancerJPRN-UMIN000006667Setouchi Breast Comprehensive Support Organaization60
尚未招募
3 期
Comparison of letrozole and Cetrolix acetate in the prevention of ovarian hyperstimulation syndromeIRCT20240627062268N1Iran University of Medical Sciences110